Recombinant Mouse VSTM2B Protein, N-His-SUMO

Description of Recombinant Mouse VSTM2B Protein, N-His-SUMO

Introduction

Recombinant Mouse VSTM2B Protein, also known as V-set and transmembrane domain containing 2B, is a type I transmembrane protein that is encoded by the VSTM2B gene in mice. It belongs to the immunoglobulin superfamily and is expressed in various tissues including the brain, spleen, and thymus. This protein has been of great interest to scientists due to its unique structure and potential therapeutic applications. In this article, we will delve into the structure, activity, and potential applications of Recombinant Mouse VSTM2B Protein.

Structure of Recombinant Mouse VSTM2B Protein

Recombinant Mouse VSTM2B Protein is composed of 318 amino acids and has a predicted molecular weight of 35.7 kDa. It contains a signal peptide at the N-terminus, a V-type Ig-like domain, a transmembrane domain, and a cytoplasmic tail. The V-type Ig-like domain is responsible for the protein’s binding activity, while the transmembrane domain anchors the protein in the cell membrane. The cytoplasmic tail is thought to be involved in intracellular signaling pathways.

Activity of Recombinant Mouse VSTM2B Protein

Recombinant Mouse VSTM2B Protein has been shown to have a variety of activities, including immune regulation and cell adhesion. It has been found to interact with various cell surface receptors, such as CD47 and SIRPα, and modulate their signaling pathways. This interaction has been shown to play a role in regulating immune responses, such as phagocytosis and T cell activation. Additionally, Recombinant Mouse VSTM2B Protein has been found to play a role in cell adhesion, particularly in neural development and synapse formation.

Applications of Recombinant Mouse VSTM2B Protein

The unique structure and activity of Recombinant Mouse VSTM2B Protein make it a promising candidate for various therapeutic applications. One potential application is in the treatment of autoimmune diseases, as the protein’s immune regulatory activity could potentially help to modulate the overactive immune response seen in these conditions. Additionally, Recombinant Mouse VSTM2B Protein could be used in the development of novel cancer therapies. Its ability to interact with cell surface receptors involved in tumor growth and metastasis could make it a valuable target for cancer treatment.

Furthermore, Recombinant Mouse VSTM2B Protein has been shown to play a role in neural development and synapse formation, suggesting its potential use in neurological disorders. Studies have shown that this protein is highly expressed in the brain and is involved in regulating synaptic plasticity, which is essential for learning and memory. Therefore, Recombinant Mouse VSTM2B Protein could potentially be used in the treatment of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.

Conclusion

In conclusion, Recombinant Mouse VSTM2B Protein is a unique type I transmembrane protein with a diverse range of activities. Its structure, which includes a V-type Ig-like domain, transmembrane domain, and cytoplasmic tail, allows it to interact with various cell surface receptors and modulate immune responses and cell adhesion. This protein has potential applications in the treatment of autoimmune diseases, cancer, and neurological disorders. Further research on Recombinant Mouse VSTM2B Protein could lead to the development of novel therapeutics for these conditions.

Keywords: Recombinant protein, antigen, VSTM2B, immune regulation, cell adhesion, autoimmune diseases, cancer, neurological disorders